0001209191-20-046419.txt : 20200812 0001209191-20-046419.hdr.sgml : 20200812 20200812172946 ACCESSION NUMBER: 0001209191-20-046419 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200810 FILED AS OF DATE: 20200812 DATE AS OF CHANGE: 20200812 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHAN NELSON C CENTRAL INDEX KEY: 0001242653 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49602 FILM NUMBER: 201096318 MAIL ADDRESS: STREET 1: C/O SYNAPTICS INCORPORATED STREET 2: 1251 MCKAY DRIVE CITY: SAN JOSE STATE: CA ZIP: 95131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNAPTICS Inc CENTRAL INDEX KEY: 0000817720 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 770118518 STATE OF INCORPORATION: DE FISCAL YEAR END: 0627 BUSINESS ADDRESS: STREET 1: 1251 MCKAY DRIVE CITY: SAN JOSE STATE: CA ZIP: 95131-3326 BUSINESS PHONE: 408-904-1100 MAIL ADDRESS: STREET 1: 1251 MCKAY DRIVE CITY: SAN JOSE STATE: CA ZIP: 95131-3326 FORMER COMPANY: FORMER CONFORMED NAME: SYNAPTICS INC DATE OF NAME CHANGE: 20010216 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-10 0 0000817720 SYNAPTICS Inc SYNA 0001242653 CHAN NELSON C 1251 MCKAY DRIVE SAN JOSE CA 95131 1 0 0 0 Common Stock 2020-08-10 4 M 0 4500 46.50 A 60993 D Common Stock 2020-08-10 4 S 0 18968 85.4588 D 42025 D Common Stock 2020-08-10 4 S 0 8013 86.1216 D 34012 D Common Stock 2020-08-10 4 S 0 1850 87.8665 D 32162 D Common Stock 2020-08-10 4 S 0 419 88.99 D 31743 D Director Stock Option (Right to Buy) 46.50 2020-08-10 4 M 0 4500 0.00 D 2020-10-28 Common Stock 4500 0 D The shares were sold pursuant to a 10b5-1 Trading Plan dated May 29,2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.81 to $85.80, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.82 to $86.71, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.55 to $87.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 1/12th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the October 28, 2013 date of grant, until fully vested on October 28, 2014. /s/ Kermit Nolan, as attorney-in-fact 2020-08-12